Neuigkeiten

Neuigkeiten

Aktuelles aus dem GMP-Umfeld und von der Valicare GmbH

Nachrichten aus aller Welt

Unser internationaler Pressespiegel zeigt eine Auswahl an Nachrichten und neusten Artikel zu den Themen Arzneimittel neuartiger Therapien (ATMP), Chimäre Antigenrezeptor(CAR)-T-Zell-Therapie, Tumor infiltrierende Lymphozyten (TIL) und biotechnologisch bearbeitete Gewebeprodukte (TEP).

FDA Approves First Topical Gene Therapy for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa

19.05.2023 | FDA

For Immediate Release: May 19, 2023 ...

A Guide to Mesenchymal Stem Cell (MSC) Markers

19.05.2023 | Biocompare

Mesenchymal stem cells are non-hematopoietic multipotent precursor cells that can differentiate into a variety of cell types, including ...

“Untargeting” autoantibodies using genome editing, a proof-of-concept study

19.05.2023 | Science Direct

... https://doi.org/10.1016/j.clim.2023.109343 ...

Imugene receives FDA approval to start human trial of CAR-T cell therapy for solid tumours

19.05.2023 | Small Caps

Cancer immunotherapy house Imugene (ASX: IMU) has received US Food and Drug Administration (FDA) approval to start a human trial targeting ...

Rescued from the rubbish bin: How the thymus could stop organ transplant rejection

18.05.2023 | BC Children's Hospital Research Institute

Polymeric nanoparticles containing babassu oil: A proposed drug delivery system for controlled release of hydrophilic compounds

18.05.2023 | Science Direct

... https://doi.org/10.1016/j.chemphyslip.2023.105304 ...

Around the Helix: Cell and Gene Therapy Company Updates – May 17, 2023

17.05.2023 | CGTLive

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

EMA Publishes Annual Report for 2022

17.05.2023 | Pharmaceutical Technology

The report outlines highlights from the agency’s medicines evaluations and milestones for 2022.

Spinnenseide für Gewebe und Implantat

17.05.2023 | medizin & technik

Evolving Tools and Perspectives for the Development of Cell and Gene Therapies

16.05.2023 | Applied Clinical Trials

This year marks the first time multiple gene therapies for the same non-oncology rare disease may be market authorized in the United States ...

FDA Awards FTD of IMPT-314 for B-Cell Mediated Malignancies

16.05.2023 | Targeted Oncology

The fast track designation to IMPT-314 is for the treatment of multiple types of B-cell lymphoma in patients who previously received 2 or ...

ReviewViral Vectors, Exosomes, and Vexosomes: Potential armamentarium for delivering CRISPR/Cas to cancer cells

16.05.2023 | Science Direct

... https://doi.org/10.1016/j.bcp.2023.115555 ...

Advanced flexible materials made from nanocellulose

16.05.2023 | Nanowerk

May 16, 2023 Advanced flexible materials made from nanocellulose ( Nanowerk Spotlight ) Nanocellulose, a specialized type of cellulose ...

Researchers map RNA to inform selection of stem cells for therapeutic applications

12.05.2023 | The Science Advisory Board

By Nick Paul Taylor, The Science Advisory Board contributing writer ...

What is the Best Lymphoma Treatment After CAR T Therapy Fails?

12.05.2023 | Cancer Health

... iStock/Catalin Rusnac CU Cancer Center member Ajay Major published research showing that checkpoint inhibitor therapies are not ...

ATMP Beratung Meeting

Wir sind für Sie da

Kontaktieren Sie uns, wenn Sie Fragen haben. Wir antworten und beraten Sie gerne. 

Kontakt